Lumos Pharma
Latest round
- Series B
Last raised
- Apr 2016
Total raised
- $47M
Investors
- 6
About Lumos Pharma
Lumos Pharma, Inc.Founded in 1999 and headquartered in Austin, US, Lumos Pharma, Inc. specializes in treatments for rare pediatric diseases. The company underwent a merger with NewLink Genetics Corporation in September 2019, transitioning into a public company. In July 2020, Lumos Pharma, Inc., Inc.Lumos Pharma focuses primarily on developing therapeutics for rare diseases, with a strong emphasis on Pediatric Growth Hormone Deficiency (PGHD). Their flagship product, LUM-201, addresses challenges faced by children suffering from PGHD, which can lead to significant growth retardation, short stature, and delayed maturation. The company’s products are primarily targeted at pediatric patients, their families, and healthcare providers specializing in endocrinology and pediatric care.Lumos Pharma reported a revenue of USD 2,051 mn for the most recent year, with an EBITDA of USD 35,873 mn.Lumos Pharma plans to expand its product offerings, with a focus on launching LUM-201 across more markets by mid-2023., which will support further clinical trials and market entry strategies. The recent Trade Sale deal is expected to bolster their financial position, allowing them to enhance product development and outreach initiatives.
Who invested in Lumos Pharma
6 investors across 3 rounds
See all investors in Lumos Pharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Lumos Pharma
Who invested in Lumos Pharma?
Lumos Pharma has 6 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Lumos Pharma raised?
Lumos Pharma has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Lumos Pharma last raise money?
Lumos Pharma's most recent round on record is a Series B, in Apr 2016.
What does Lumos Pharma do?
Lumos Pharma is a biotechnology company.
Where is Lumos Pharma headquartered?
Lumos Pharma is headquartered in Austin, US.
Which VCs invest in companies like Lumos Pharma?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Lumos Pharma's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Lumos Pharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.